Diana Brainard - Nov 11, 2021 Form 3 Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role: Director
Signature: Mark A. Wilson, Attorney-in-Fact
Stock symbol: NKTR
Transactions as of: Nov 11, 2021
Transactions value $: $0
Form type: 3
Date filed: 11/15/2021, 04:06 PM
Previous filing: May 18, 2021
Next filing: Apr 4, 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24.1 - Power of Attorney